Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/22/08 → 11/23/10 |
Funding
- Cadence Pharmaceuticals: $5,366.02
A Phase IIIB Multi-Center, Open-Label, Prospective, Repeated Dose, Multi-Day Study of the Safety and Efficacy of Intravenous Acetaminophen in Pediatric Inpatients
- Egnor, Michael (CoPI)
- Jasiewicz, Ronald (CoPI)
- Seidman, Peggy (PI)
- Jacob, Zvi (CoPI)
Project: Research